$4.87+0.16 (+3.40%)
Cardlytics, Inc.
Cardlytics, Inc. in the Communication Services sector is trading at $4.87 with a market capitalization of $30M. Wall Street consensus targets $10.75 (4 analysts), implying a +120.7% move over the next 12 months. The stock is currently near its 52-week low of $4.50, remaining 58.2% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $34.32Mβ | $56.09Mβ | $52.03Mβ | $63.25Mβ | $56.44M |
| Gross Profit | $17.14Mβ | $25.89Mβ | $24.30Mβ | $29.26Mβ | $21.55M |
| Operating Income | -$8.27Mβ | -$4.10Mβ | -$9.69Mβ | -$12.55Mβ | -$16.41M |
| Net Income | -$4.48Mβ | -$8.25Mβ | -$72.67Mβ | -$9.28Mβ | -$13.28M |
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company provides Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through digital channels,...
We recently compiled a list of the 10 Best Penny Stocks Under $1 According to Hedge Funds. Cardlytics, Inc. (NASDAQ:CDLX) is among the best penny stocks. TheFly reported on May 8 that Lake Street reduced its price target on CDLX to $1.25 from $1.50 while reiterating a Hold rating, citing a reset in expectations following [β¦]
As you might know, Cardlytics, Inc. ( NASDAQ:CDLX ) just kicked off its latest quarterly results with some very strong...
Amit Gupta: Good evening, and thank you for joining us. First, expanding our reach by deepening collaborations with bank partners and integrating new publishers into our network; second, driving incremental revenue growth for our advertisers by leveraging our advanced algorithmic and geo-centric capabilities; and third, continuing to invest in our technology platform to further differentiate our offering and improve operational efficiency.
Moby summary of Cardlytics, Inc.'s Q1 2026 earnings call
Cardlytics is back in focus after analysts reset price targets closer to the US$1 to US$1.25 range, with a fair value estimate holding near US$1.04. These changes sit alongside commentary that Q4 results, Q1 guidance, the BofA exit, and the Bridg divestiture now leave the "bar appropriately level set," with some calling the shares firmly in "show me" territory. As you read on, you will see how to track this evolving analyst narrative and what it can mean for your own view on the stock. Stay...